Gastric Cancer After D2 Lymph Node Dissection
Conditions
Brief summary
Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.
Interventions
DRUGSomatostatin
Somatostatin is a kind of traditional medicines ,which is for the treatment of intestinal fistula，upper gastrointestinal hemorrhage.
Sponsors
First Affiliated Hospital, Sun Yat-Sen University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
1. More than eighteen years old 2. Gastric cancer diagnosed by pathological examination 3. Be given informed consent 4. Without diabetes/hyperthyroidism/Damages of functions of heart, liver and kidney/Systemic Infection/immunodeficiency
Exclusion criteria
1. Contraindication of vascular puncture operation 2. Patients who refused to take part in the programe 3. Poor compliance of treatment 4. Malnutrition,BMI\<18 5. with pancreatectomy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| fistula of pancreas | one year | number of patients |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| amount of bleeding | six months | amount of bleeding after the operation |
| seroperitoneum | six months | seroperitoneum volum of patients |
| infection of incisional wound | one year | number of patients |
Other
| Measure | Time frame | Description |
|---|---|---|
| postoperative pancreatitis | one year | number of patients |
Outcome results
None listed